Timothy S. Olson, Alexis A. Thompson, Janet L. Kwiatkowski, Jennifer Schneiderman, Isabelle Thuret, Andreas E. Kulozik, Evangelia Yannaki, Marina Cavazzana, Suradej Hongeng, Martin G. Sauer, Adrian J. Thrasher, Ashutosh Lal, John E.J. Rasko, Hancheng Jiang, Ge Tao, Himal L. Thakar, Niki Witthuhn, Mark C. Walters, Franco Locatelli. Betibeglogene Autotemcel (Beti-cel) Gene Addition Therapy Results in Durable Hemoglobin A (HbA) Production with up to 10 Years of Follow-up in Participants with Transfusion-Dependent ß-Thalassemia. Transplantation and Cellular Therapy. 2025 Feb 1; 31(2):s20.